SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Pharma - Quaterly Results

10 Aug 2023 Evaluate
The sales surged to Rs. 1829.20 millions, up 39.65% for the June 2023 quarter as against Rs. 1309.88 millions during the corresponding quarter previous year.The Total Profit for the quarter ended June 2023 of Rs. 107.75 millions grew from Rs.-140.88 millionsOperating profit surged to 240.28 millions from the corresponding previous quarter of 153.81 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 1829.20 1309.88 39.65 1829.20 1309.88 39.65 6658.98 5569.74 19.56
Other Income 18.86 29.31 -35.65 18.86 29.31 -35.65 194.31 90.03 115.83
PBIDT 240.28 153.81 56.22 240.28 153.81 56.22 1030.49 662.62 55.52
Interest 55.45 78.40 -29.27 55.45 78.40 -29.27 322.26 320.12 0.67
PBDT 184.83 75.41 145.10 184.83 75.41 145.10 1100.33 342.50 221.26
Depreciation 77.08 216.29 -64.36 77.08 216.29 -64.36 547.86 870.21 -37.04
PBT 107.75 -140.88 -176.48 107.75 -140.88 -176.48 552.47 -527.71 -204.69
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 107.75 -140.88 -176.48 107.75 -140.88 -176.48 552.47 -527.71 -204.69
Equity 507.19 408.16 24.26 507.19 408.16 24.26 408.16 408.16 0.00
PBIDTM(%) 13.14 11.74 11.87 13.14 11.74 11.87 15.48 11.90 30.08

Orchid Pharma Share Price

565.15 1.05 (0.19%)
17-Apr-2026 13:06 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.60
Dr. Reddys Lab 1229.90
Cipla 1234.45
Zydus Lifesciences 944.20
Lupin 2308.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×